Status:
COMPLETED
Safety and Effects of Ramipril Combined With Candesartan
Lead Sponsor:
Gachon University Gil Medical Center
Conditions:
Hypertension
Eligibility:
All Genders
35-75 years
Phase:
PHASE4
Brief Summary
we hypothesized that combination therapy has additive beneficial effects to improve endothelial dysfunction and adipocytokine profiles in patients with hypertension.
Detailed Description
Forty patients will be given ramipril 10 mg and placebo, ramipril 10 mg and candesartan 16 mg, or candesartan 16 mg and placebo daily in a randomized, double-blind, placebo-controlled cross-over trial...
Eligibility Criteria
Inclusion
- patients with mild to moderate hypertension
Exclusion
- We will exclude patients with severe hypertension, unstable angina, acute myocardial infarction, or renal insufficiency.
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
End Date :
March 1 2006
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00356395
Start Date
August 1 2003
End Date
March 1 2006
Last Update
July 26 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.